AirICU belongs to the feellife group, a healthcare company centered around treating the upper and lower respiratory tracts of the human body. With the vision of "The Third Way of Dosing" and the technology core of "AiMesh ®" polymer nebulizer, feellife owns more than 250+ international invention patents and certificates, taking the leading position in the field of nebulized drug delivery, and the clinical nebulization equipment for hospital intensive care represented by "AirICU" has already benefited millions of patients in more than 40 countries and regions.
Founded the Center for Respiratory Disease Conservation in the United States.
Founded feellife Health Inc., focusing on the research, development and production of intelligent vibrating mesh nebulizer.
Created a global nebulized liquid ecological business model of intelligent nebulizer + nebulized liquid.
Launch the first AI intelligent nebulizer with imesh core technology worldwide.
Combination of global mesh nebulization ecology and modern traditional Chinese medicine innovation.
Global preferred supplier of nebulized vaccine equipment.
Received the "World's Best Home Nebulizer Solution" award from the European media.
Received the Global Vaccine Equipment Expert of the Year Award from Global Health & Medicine.
Received MedTech Top 20 Innovative Healthcare Companies in the U.S.
Air Smart Extra Lung Function Tester receives FDA K number.
Received HCA Asia's Hospital Partnership of the Year.
AirICU has been recognized by the medical and product design industry for its technology over the years.
We take pride in responding to your questions and comments
中国大陆
简体中文
United Kingdom
English
